Hino K - Search Results

1

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, Izumi N, Yamasaki T, Nojiri S, Hino K, Tsumura H, Kuzuya T, Isoda N, Yasui K, Aino H, Ido A, Kawabe N, Nakao K, Wada Y, Yokosuka O, Yoshimura K, Okusaka T, Furuse J, Kokudo N, Okita K, Johnson PJ, Arai Y; TACTICS study group. Kudo M, et al. Among authors: hino k. Gut. 2020 Aug;69(8):1492-1501. doi: 10.1136/gutjnl-2019-318934. Epub 2019 Dec 4. Gut. 2020. PMID: 31801872 Free PMC article. Clinical Trial.

2

Current strategies for chemoprevention of hepatocellular carcinoma.

Okita K, Sakaida I, Hino K. Okita K, et al. Among authors: hino k. Oncology. 2002;62 Suppl 1:24-8. doi: 10.1159/000048272. Oncology. 2002. PMID: 11868781 Review.

3

Expression of type I interferon receptor in liver and peripheral blood mononuclear cells in chronic hepatitis C patients.

Yamaguchi Y, Hino K, Fujiwara D, Ren F, Katoh Y, Satoh Y, Okita K. Yamaguchi Y, et al. Among authors: hino k. Dig Dis Sci. 2002 Jul;47(7):1611-7. doi: 10.1023/a:1015887723557. Dig Dis Sci. 2002. PMID: 12141824

4

Hepatic expression of type I interferon receptor for predicting response to interferon therapy in chronic hepatitis C patients: a comparison of immunohistochemical method vs. competitive polymerase chain reaction assay.

Fujiwara D, Hino K, Yamaguchi Y, Ren F, Satoh Y, Korenaga M, Okuda M, Okita K. Fujiwara D, et al. Among authors: hino k. Hepatol Res. 2003 Apr;25(4):377-384. doi: 10.1016/s1386-6346(02)00312-1. Hepatol Res. 2003. PMID: 12699848

5

Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.

Ren F, Hino K, Yamaguchi Y, Funatsuki K, Hayashi A, Ishiko H, Furutani M, Yamasaki T, Korenaga K, Yamashita S, Konishi T, Okita K. Ren F, et al. Among authors: hino k. J Med Virol. 2003 Nov;71(3):376-84. doi: 10.1002/jmv.10509. J Med Virol. 2003. PMID: 12966542 Clinical Trial.

6

Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C.

Hino K, Okita K. Hino K, et al. J Antimicrob Chemother. 2004 Jan;53(1):19-22. doi: 10.1093/jac/dkh031. Epub 2003 Dec 4. J Antimicrob Chemother. 2004. PMID: 14657083 Review.

7

[Genetic variability and clinical significance of hypervariable region of hepatitis C virus].

Hino K, Korenaga M, Okuda M, Okita K. Hino K, et al. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):385-90. Nihon Rinsho. 2004. PMID: 15359827 Review. Japanese. No abstract available.

8

[Molecular analysis of hepatitis C virus in pathogenesis of chronic hepatitis C].

Yamaguchi Y, Okita K, Hino K. Yamaguchi Y, et al. Among authors: hino k. Nihon Rinsho. 2004 Jul;62 Suppl 7(Pt 1):422-5. Nihon Rinsho. 2004. PMID: 15359835 Review. Japanese. No abstract available.

9

[Clinical aspects of TTV infection].

Hino K, Okita K. Hino K, et al. Nihon Rinsho. 2004 Aug;62 Suppl 8:570-4. Nihon Rinsho. 2004. PMID: 15453385 Review. Japanese. No abstract available.

10

Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.

Satoh Y, Hino K, Kato T, Mizokami M, Yamashita S, Nakamura H, Okita K. Satoh Y, et al. Among authors: hino k. J Gastroenterol Hepatol. 2004 Nov;19(11):1305-11. doi: 10.1111/j.1440-1746.2004.03444.x. J Gastroenterol Hepatol. 2004. PMID: 15482539

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

576 results

Search Page